Welcome to our dedicated page for Aveanna Healthcare Holdings news (Ticker: AVAH), a resource for investors and traders seeking the latest updates and insights on Aveanna Healthcare Holdings stock.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is described as a diversified home care platform focused on medically complex, high-cost patient populations, with headquarters in Atlanta, Georgia and locations in 38 states. The AVAH news page on Stock Titan aggregates company press releases and market updates that explain how Aveanna delivers pediatric and adult nursing, therapy, home health, hospice, and medical product services in home and community settings.
Visitors to this page can review Aveanna’s own announcements on topics such as updated full year financial guidance, preliminary and final quarterly results, and commentary on non-GAAP measures like EBITDA, Adjusted EBITDA, and Normalized Adjusted EBITDA. News items also cover participation in healthcare and finance conferences, including events hosted by financial institutions, where the company’s management presents to investors and holds one-on-one meetings.
Other Aveanna releases describe capital markets activity and financing developments, such as secondary offerings of common stock by existing stockholders and amendments to credit facilities and term loans. These updates provide context on the company’s capital structure, refinancing transactions, and relationships with lenders and underwriters.
Because Aveanna positions its services as a high quality, lower cost alternative to prolonged hospitalization, news about its financial performance, strategic financing actions, and investor presentations can be relevant to those tracking trends in home-based care for medically fragile and chronically ill children and adults. For ongoing coverage of AVAH, investors and observers can use this page to follow the company’s reported milestones, regulatory disclosures referenced in press releases, and other public communications.
Aveanna Healthcare (NASDAQ: AVAH) announced that Aveanna Home Health and Hospice earned CHAP Disease Program Certification for Heart Failure on Feb 11, 2026. CHAP certification recognizes program structure, clinician education, quality metrics, and patient self-management tools under nationally recognized standards.
The certified Heartways program provides evidence-based care pathways for home health and hospice patients, aiming to reduce hospitalizations, improve symptom management, and strengthen patient and caregiver education.
Summary not available.
Aveanna (NASDAQ: AVAH) announced that management will attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and will present on January 14, 2026.
The presentation is scheduled for 9:45 a.m. PST on January 14, 2026, followed by one-on-one investor meetings the same day. Interested parties can listen via a simultaneous webcast at https://ir.aveanna.com/. An online replay will be available for a limited time shortly after the call.
Aveanna (NASDAQ: AVAH) announced that management will participate virtually in the BofA Securities Home Care Conference on December 9, 2025.
Management will present at 12:30 PM ET, hold one-on-one investor meetings the same day, and offer a simultaneous webcast available via the company Investor Relations website with an online replay posted for a limited time.
Aveanna Healthcare (NASDAQ: AVAH) reported Q3 2025 revenue $621.9M (+22.2% YoY) and net income $14.1M versus a prior-year net loss. Q3 Adjusted EBITDA $80.1M (12.9% margin, +67.5% YoY). Nine-month revenue was $1.7707B (+17.7%) with Adjusted EBITDA $235.9M (+83.7%).
The company raised full-year 2025 guidance to revenue >$2.375B and Adjusted EBITDA >$300M. Liquidity: cash of $145.9M, securitization capacity $105.8M, undrawn revolver capacity ~$227M (≈$23M letters of credit). Total indebtedness was $1,490.0M; 2025 Term Loans bear interest at Term SOFR +3.75%. Free cash flow for nine months was $86.2M.
Aveanna Healthcare (NASDAQ: AVAH) announced the pricing of a secondary offering by selling stockholders affiliated with J.H. Whitney Equity Partners VII: 10,000,000 shares priced at $9.00 per share, with underwriters granted a 30-day option to buy up to an additional 1,500,000 shares.
The company will not sell shares or receive proceeds from the Offering. The sale is expected to settle on October 23, 2025, subject to customary closing conditions. A Form S-3 shelf registration (declared effective) and prospectus supplement are available through the SEC EDGAR system.
Aveanna Healthcare (NASDAQ: AVAH) announced on October 21, 2025 that certain selling stockholders affiliated with J.H. Whitney Equity Partners VII have commenced a secondary offering of 10,000,000 shares of common stock, with underwriters granted a 30-day option to purchase up to an additional 1,500,000 shares.
The selling stockholders will receive all net proceeds; the company is not offering shares and will not receive any proceeds from the sale. Jefferies and J.P. Morgan are joint lead book-running managers; Barclays and RBC are bookrunners. A Form S-3 shelf registration (including a prospectus) has been filed and declared effective by the SEC.
Aveanna Healthcare (NASDAQ: AVAH) reported preliminary results for the three-month period ended September 27, 2025. Management expects revenue of $616M–$624M, up ~21.0%–22.6% year-over-year; net income of $11M–$15M, up ~125.7%–135.0% year-over-year; and Adjusted EBITDA of $77M–$81M, up ~61.0%–69.3% year-over-year.
Results are preliminary and unaudited, subject to closing procedures and potential material adjustments. The company disclosed significant non-GAAP adjustments, including $15.7M–$16.9M of fees related to debt modifications and various acquisition and integration costs.
Aveanna (NASDAQ: AVAH) will release its third quarter 2025 results before the market open on Thursday, November 6, 2025, followed by a conference call at 10:00 a.m. ET the same day.
Investors can join the live call by dialing 1-877-407-0789 (U.S.) or 1-201-689-8562 (international). A replay will be available three hours after the call by dialing 1-844-512-2921 (U.S.) or 1-412-317-6671 (international) using passcode 13755427. The telephone replay is available until November 13, 2025, and a simultaneous webcast and online replay will be hosted on the company Investor Relations website at https://ir.aveanna.com/.
Aveanna Healthcare Holdings (NASDAQ: AVAH) announced its management team will participate in the Deutsche Bank Annual Leveraged Finance Conference in Austin, TX on October 15, 2025. During the conference, the management will be available for one-on-one meetings with investors.
FAQ
What is the current stock price of Aveanna Healthcare Holdings (AVAH)?
What is the market cap of Aveanna Healthcare Holdings (AVAH)?
